Abstract
Hypertension is common in HFpEF and guidelines recommend an SBP<130 mmHg in HFpEF. Sacubitril/valsartan (S/V) significantly reduces SBP in HFrEF and HTN. In PARAGON-HF, we related baseline SBP (continuous and quartiles [<120, 120-129, 130-139, ≥140 mmHg]) to the primary outcome (CV death or
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
